Genomics Personalized Health Market By Technology (NGS platforms, RT-PCR, Microarray, and Genetic Analyzers), By Test Type (Oncology Testing, Infectious Disease Testing, Autoimmune Disease Testing, and Others), By End-User (Academics & Research Institutes, Diagnostic Centers, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Global Genomics Personalized Health Market size is set to expand from $ 9.28 Billion in 2023 to $ 31.01 Billion by 2032, with an anticipated CAGR of around 12.8% from 2024 to 2032.

全球基因组学个性化健康管理市场预计将从2023年的92.8亿美元增长至2032年的310.1亿美元，预计2024年至2032年间的年复合增长率约为12.8%。